Geffken Daniel E. has filed 3 insider transactions across 3 companies since October 2023.
Most recent transaction: a grant/award of 10000 shares of CalciMedica, Inc. ($CALC) on May 17, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | CalciMedica, Inc. | $CALC | Geffken Daniel E. | Interim CFO | A | Warrant | 10000 | $0.00 | 10,000.0000 | 4,486,258 | 9999.99% | 0.22% |
| Feb. 14, 2024 | CERO THERAPEUTICS HOLDINGS, INC. | $CERO | Geffken Daniel E. | Chief Financial Officer | J | Class A Common Stock | 10002 | $0.00 | 10,002.0000 | 292 | 9999.99% | 100.00% |
| Oct. 26, 2023 | ProMIS Neurosciences Inc. | $PMN | Geffken Daniel E. | Chief Financial Officer | A | Option (right to buy) | 2500 | $0.00 | 2,500.0000 | 12,370,830 | 9999.99% | 0.02% |